Boston Partners lowered its holdings in shares of Cadre Holdings, Inc. (NYSE:CDRE - Free Report) by 58.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,636 shares of the company's stock after selling 12,398 shares during the quarter. Boston Partners' holdings in Cadre were worth $279,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CDRE. Assetmark Inc. bought a new stake in Cadre in the 4th quarter valued at $31,000. Harel Insurance Investments & Financial Services Ltd. grew its position in shares of Cadre by 51.9% during the fourth quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,066 shares of the company's stock valued at $99,000 after purchasing an additional 1,048 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Cadre in the fourth quarter worth about $100,000. US Bancorp DE boosted its stake in Cadre by 10.6% during the fourth quarter. US Bancorp DE now owns 4,178 shares of the company's stock valued at $135,000 after buying an additional 400 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in Cadre by 1,451.5% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,251 shares of the company's stock valued at $137,000 after buying an additional 3,977 shares during the last quarter. Institutional investors own 43.95% of the company's stock.
Insider Buying and Selling at Cadre
In other Cadre news, CEO Warren B. Kanders sold 50,000 shares of Cadre stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $31.88, for a total value of $1,594,000.00. Following the transaction, the chief executive officer now owns 10,866,192 shares in the company, valued at $346,414,200.96. The trade was a 0.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 37.00% of the stock is currently owned by corporate insiders.
Cadre Price Performance
CDRE stock traded up $0.27 during trading on Thursday, hitting $30.64. 226,683 shares of the company's stock traded hands, compared to its average volume of 237,684. The business has a fifty day simple moving average of $35.14 and a 200 day simple moving average of $35.23. Cadre Holdings, Inc. has a 52 week low of $29.19 and a 52 week high of $40.28. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.96 and a current ratio of 3.01. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of 36.92, a P/E/G ratio of 1.58 and a beta of 1.30.
Cadre (NYSE:CDRE - Get Free Report) last released its quarterly earnings results on Tuesday, March 11th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.48 by ($0.16). The company had revenue of $175.98 million for the quarter, compared to analysts' expectations of $170.95 million. Cadre had a net margin of 6.34% and a return on equity of 12.88%. The business's quarterly revenue was up 41.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.25 EPS. As a group, research analysts expect that Cadre Holdings, Inc. will post 1.05 EPS for the current fiscal year.
Cadre Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Friday, January 31st were issued a dividend of $0.095 per share. This is an increase from Cadre's previous quarterly dividend of $0.09. This represents a $0.38 annualized dividend and a yield of 1.24%. The ex-dividend date of this dividend was Friday, January 31st. Cadre's dividend payout ratio (DPR) is presently 42.22%.
About Cadre
(
Free Report)
Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.
Featured Stories

Before you consider Cadre, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cadre wasn't on the list.
While Cadre currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.